Yu‐Chi Chen

1.7k total citations
66 papers, 1.1k citations indexed

About

Yu‐Chi Chen is a scholar working on Molecular Biology, Immunology and Pharmacology. According to data from OpenAlex, Yu‐Chi Chen has authored 66 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 17 papers in Immunology and 9 papers in Pharmacology. Recurrent topics in Yu‐Chi Chen's work include Biological and pharmacological studies of plants (7 papers), Immune Cell Function and Interaction (6 papers) and Immune Response and Inflammation (5 papers). Yu‐Chi Chen is often cited by papers focused on Biological and pharmacological studies of plants (7 papers), Immune Cell Function and Interaction (6 papers) and Immune Response and Inflammation (5 papers). Yu‐Chi Chen collaborates with scholars based in China, United States and Macao. Yu‐Chi Chen's co-authors include Fangmei Zhou, Bingqi Zhu, Zhishan Ding, Jin‐Jian Lu, Mu‐Yang Huang, Xiuping Chen, Yulian Xu, Shi Wei, Scott E. Martin and Jiajie Shi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Functional Materials and Cancer Research.

In The Last Decade

Yu‐Chi Chen

59 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Chi Chen China 19 465 297 139 137 115 66 1.1k
Angeliki Xagorari Greece 11 490 1.1× 274 0.9× 88 0.6× 67 0.5× 159 1.4× 20 1.3k
Eeva Moilanen Finland 16 552 1.2× 367 1.2× 93 0.7× 51 0.4× 85 0.7× 30 1.7k
Jianping Zuo China 20 725 1.6× 466 1.6× 160 1.2× 71 0.5× 128 1.1× 49 1.7k
Akinori Yanaka Japan 20 697 1.5× 209 0.7× 102 0.7× 77 0.6× 139 1.2× 81 1.4k
Rohit Gundamaraju Australia 20 854 1.8× 154 0.5× 143 1.0× 94 0.7× 143 1.2× 61 1.4k
Linda Vong Canada 15 524 1.1× 413 1.4× 85 0.6× 94 0.7× 136 1.2× 37 1.4k
Lifei Hou United States 27 460 1.0× 654 2.2× 212 1.5× 64 0.5× 129 1.1× 59 1.6k
Jian Gang Zhang China 20 351 0.8× 303 1.0× 231 1.7× 56 0.4× 76 0.7× 38 1.1k
Kyoung‐Jin Jang South Korea 16 468 1.0× 257 0.9× 113 0.8× 267 1.9× 94 0.8× 36 1.1k
Aditi Banerjee United States 21 628 1.4× 515 1.7× 248 1.8× 87 0.6× 205 1.8× 60 1.6k

Countries citing papers authored by Yu‐Chi Chen

Since Specialization
Citations

This map shows the geographic impact of Yu‐Chi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Chi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Chi Chen more than expected).

Fields of papers citing papers by Yu‐Chi Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Chi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Chi Chen. The network helps show where Yu‐Chi Chen may publish in the future.

Co-authorship network of co-authors of Yu‐Chi Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Chi Chen. A scholar is included among the top collaborators of Yu‐Chi Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Chi Chen. Yu‐Chi Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bollu, Vishnu Sravan, Yu‐Chi Chen, Fan Zhang, et al.. (2025). Managing telomerase and telomere dysfunction in acral melanoma. Pharmacological Research. 215. 107700–107700. 1 indexed citations
3.
Chen, Yu‐Chi, et al.. (2025). Quantification of the Loess Plateau's soil hydrodynamics in relation to bulk density. Soil Science Society of America Journal. 89(2).
4.
5.
Zhao, Mengjia, et al.. (2024). Tetrastigma hemsleyanum polysaccharide combined with doxorubicin promote ferroptosis and immune function in triple-negative breast cancer. International Journal of Biological Macromolecules. 275(Pt 1). 133424–133424. 10 indexed citations
6.
Zhu, Bingqi, et al.. (2024). Structure of a polysaccharide MDP2-1 from Melastoma dodecandrum Lour. and its anti-inflammatory effects. International Journal of Biological Macromolecules. 265. 131015–131015. 18 indexed citations
7.
Chen, Yu‐Chi, et al.. (2024). Rigid Vegetation Affects Slope Flow Velocity. Water. 16(16). 2240–2240. 2 indexed citations
8.
Liu, Yang, Bingqi Zhu, Yu‐Chi Chen, et al.. (2024). Tetrastigma hemsleyanum polysaccharides alleviate imiquimod-induced psoriasis-like skin lesions in mice by modulating the JAK/STAT3 signaling pathway. Phytomedicine. 133. 155917–155917. 14 indexed citations
9.
Bao, Xiaodan, Yang Liu, Yu‐Chi Chen, et al.. (2024). Tetrastigma hemsleyanum polysaccharide ameliorated ulcerative colitis by remodeling intestinal mucosal barrier function via regulating the SOCS1/JAK2/STAT3 pathway. International Immunopharmacology. 137. 112404–112404. 14 indexed citations
10.
Zhu, Bingqi, et al.. (2024). Tetrastigma hemsleyanum polysaccharide ameliorates cytokine storm syndrome via the IFN-γ-JAK2/STAT pathway. International Journal of Biological Macromolecules. 275(Pt 1). 133427–133427. 8 indexed citations
11.
Chen, Xingcan, Yu‐Chi Chen, Bingqi Zhu, et al.. (2023). Polysaccharides from Tetrastigma Hemsleyanum Diels et Gilg ameliorated inflammatory bowel disease by rebuilding the intestinal mucosal barrier and inhibiting inflammation through the SCFA-GPR41/43 signaling pathway. International Journal of Biological Macromolecules. 250. 126167–126167. 50 indexed citations
12.
Chen, Xingcan, Yu‐Chi Chen, Xiaoqing Ye, et al.. (2023). A Berberine-Loaded Bletilla striata Polysaccharide Hydrogel as a New Medical Dressing for Diabetic Wound Healing. International Journal of Molecular Sciences. 24(22). 16286–16286. 26 indexed citations
13.
Wu, Qian, Yu‐Chi Chen, Bingqi Zhu, et al.. (2023). Bletilla striata polysaccharides protect against ARDS by modulating the NLRP3/caspase1/GSDMD and HMGB1/TLR4 signaling pathways to improve pulmonary alveolar macrophage pyroptosis. Journal of Ethnopharmacology. 319(Pt 3). 117361–117361. 18 indexed citations
14.
15.
Dinavahi, Saketh S., Yu‐Chi Chen, Arthur Berg, et al.. (2022). Targeting WEE1/AKT Restores p53-Dependent Natural Killer–Cell Activation to Induce Immune Checkpoint Blockade Responses in “Cold” Melanoma. Cancer Immunology Research. 10(6). 757–769. 23 indexed citations
16.
Chen, Yu‐Chi, Qi Lu, Shi Wei, et al.. (2022). Myricetin inhibits interferon-γ-induced PD-L1 and IDO1 expression in lung cancer cells. Biochemical Pharmacology. 197. 114940–114940. 34 indexed citations
17.
Li, Minghua, Max Ferretti, Baoling Ying, et al.. (2021). Pharmacological activation of STING blocks SARS-CoV-2 infection. Science Immunology. 6(59). 143 indexed citations
18.
Li, Xueping, Shujun Wei, Huan Yao, et al.. (2019). Lingguizhugan decoction attenuates doxorubicin-induced heart failure in rats by improving TT-SR microstructural remodeling. BMC Complementary and Alternative Medicine. 19(1). 360–360. 24 indexed citations
19.
Al‐Ramahi, Ismael, Sai Srinivas Panapakkam Giridharan, Yu‐Chi Chen, et al.. (2017). Inhibition of PIP4Kγ ameliorates the pathological effects of mutant huntingtin protein. eLife. 6. 51 indexed citations
20.
Tang, Shou‐Hung, Sheng‐Tang Wu, Yu‐Chi Chen, et al.. (2015). Novel Cancer Therapeutics with Allosteric Modulation of the Mitochondrial C-Raf–DAPK Complex by Raf Inhibitor Combination Therapy. Cancer Research. 75(17). 3568–3582. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angeliki Xagorari Breakdown of academic impact, for papers by Eeva Moilanen Breakdown of academic impact, for papers by Jianping Zuo Breakdown of academic impact, for papers by Akinori Yanaka Breakdown of academic impact, for papers by Rohit Gundamaraju Breakdown of academic impact, for papers by Linda Vong Breakdown of academic impact, for papers by Lifei Hou Breakdown of academic impact, for papers by Jian Gang Zhang Breakdown of academic impact, for papers by Kyoung‐Jin Jang Breakdown of academic impact, for papers by Aditi Banerjee
Rankless by CCL
2026